Zobrazeno 1 - 10 of 12 pro vyhledávání: '"Yvonne, Lis"'
1
Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals: Report of the International Society for Pharmacoeconomics and Outcomes Research Risk Benefit Management Working Group
Autor: Dennis W. Raisch, S. Kamble, Yvonne Lis, Jeff J. Guo, Melissa H. Roberts
Publikováno v: Value in Health. 15:1108-1118
Objective 1) To compare the Food and Drug Administration's (FDA's) Risk Evaluation and Mitigation Strategies (REMS) and European Medicines Agency's (EMA's) Risk Management Plan (RMP) guidances and 2) to compare REMS and RMPs for specific chemical ent
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc601148dca7495411d27299049e7a9
https://doi.org/10.1016/j.jval.2012.06.019
Zobrazit plný text záznamu
2
Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines
Autor: Silke Fähnrich, Hans G. Drexler, Yvonne Lis, Roderick A.F. MacLeod, Elisabeth Becker, W. G. Dirks
Publikováno v: International Journal of Cancer. 100:49-56
The initial identification of the ALK gene, expressed as C-terminal part of the transforming fusion protein NPM-ALK in the t(2;5)(p23;q35) lymphoma-associated chromosomal translocation, revealed a novel receptor tyrosine kinase (RTK). In order to exp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0c3cf5adc14358ce17a8b3ddd387f774
https://doi.org/10.1002/ijc.10435
Zobrazit plný text záznamu
3
A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women
Autor: Yvonne Lis, Ronald D. Mann, D.O. Chanter, J. Chukwujindu
Publikováno v: Journal of Clinical Epidemiology. 47:307-312
The initial results are reported of a case-control study undertaken on the VAMP multi-purpose database and designed to estimate the risk for first-time occurrence of myocardial infarction in users of hormone replacement therapy (HRT). The findings cu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd1d1f92828e9d077f4d9769e16b5c35
https://doi.org/10.1016/0895-4356(94)90014-0
Zobrazit plný text záznamu
6
A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group
Autor: Dennis W. Raisch, Yvonne Lis, John Doyle, Jeff J. Guo, B. Bian, Swapnil Pandey
Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 13(5)
Objective: Although regulatory authorities evaluate the risks and benefits of any new drug therapy during the new drug-approval process, quantitative risk–benefit assessment (RBA) is not typically performed, nor is it presented in a consistent and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1156244de0324c0509cdeb5e675c82c
https://pubmed.ncbi.nlm.nih.gov/20412543
Zobrazit plný text záznamu
7
The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases
Autor: Mel Walker, Yvonne Lis, Warren Cowell, Eamonn Brankin, Niall Lynch, Terence J. Aspray
Publikováno v: Current medical research and opinion. 22(7)
Bisphosphonates are currently among the most effective therapies for the treatment of osteoporosis and provide one of the mainstays of treatment in the UK. However studies in several countries have all reported sub-optimal compliance and persistence
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a24e0cc2349d8c855f9205c37259eb9
https://pubmed.ncbi.nlm.nih.gov/16834823
Zobrazit plný text záznamu
8
Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines
Autor: Willy G, Dirks, Silke, Fähnrich, Yvonne, Lis, Elisabeth, Becker, Roderick A F, MacLeod, Hans G, Drexler
Publikováno v: International journal of cancer. 100(1)
The initial identification of the ALK gene, expressed as C-terminal part of the transforming fusion protein NPM-ALK in the t(2;5)(p23;q35) lymphoma-associated chromosomal translocation, revealed a novel receptor tyrosine kinase (RTK). In order to exp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f93efd8883e5816110d91273805d5ef6
https://pubmed.ncbi.nlm.nih.gov/12115586
Zobrazit plný text záznamu
10
What Is Known about the Clinical and Economic Burden of Refractory Chronic Lymphocytic Leukemia in Clinical Practice: A Review of the Literature
Autor: Radek Wasiak, Vincent Levy, Gwilym J. Thompson, K Payne, Yvonne Lis
Publikováno v: Blood. 114:4549-4549
Abstract 4549 Introduction Chronic lymphocytic leukemia (CLL) is the most common adult haematological malignancy in the Western world. It remains incurable and follows an extremely variable clinical course with survival ranging from months to decades
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fdb89ed51e4209d33b069669eb484dad
https://doi.org/10.1182/blood.v114.22.4549.4549
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje